Hematogones are benign lymphocyte precursors with dense, homogenous chromatin and a high nuclear-to-cytoplasmic ratio. They may be seen as part of an exaggerated B-cell recovery in response to chemotherapy or infiltration of the marrow from a non-hematologic tumor.